PMC4366987_01
(a) Patient at 11 weeks of age, before receiving nadolol treatment. (b) Patient at 21 weeks of age, after 10 weeks of treatment
JFMPC-4-135-g001.jpg
PMC4366987_02_JFMPC-4-135-g001.jpg
F1
Within 3 weeks there was marked decrease in the redness, vascularity, and elevation of the hemangioma, including over the lower eyelid [Figure 1].
PMC4366987_02
(a) Patient at 11 weeks of age, before receiving nadolol treatment. (b) Patient at 21 weeks of age, after 10 weeks of treatment
JFMPC-4-135-g001.jpg
PMC4366987_02_JFMPC-4-135-g001.jpg
F1
Within 3 weeks there was marked decrease in the redness, vascularity, and elevation of the hemangioma, including over the lower eyelid [Figure 1].